Equities research analysts at StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) in a research note issued to investors on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of GLMD stock opened at $3.34 on Friday. Galmed Pharmaceuticals has a 52-week low […]
StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) in a research note released on Friday. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Galmed Pharmaceuticals stock opened at $4.09 on Friday. The stock has a 50-day moving average of $4.86 and a two-hundred day […]
StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) in a report released on Thursday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of GLMD stock opened at $4.74 on Thursday. The stock’s 50 day simple moving average is $5.08 and its 200 day […]
StockNews.com began coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) in a research report report published on Wednesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance Shares of GLMD stock opened at $4.60 on Wednesday. The stock has a market capitalization of $7.73 million, a PE […]
StockNews.com began coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) in a research report sent to investors on Tuesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance GLMD opened at $5.00 on Tuesday. The stock has a market cap of $8.41 million, a P/E ratio of […]